Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
12/22/2009 | US7635759 Gene encoding labyrinthin, a marker for cancer |
12/22/2009 | US7635757 Nucleotide sequence which hybridizes to the complement of the specific nucleic acid molecule over its full length under conditions of incubation and encodes a polypeptide which costimulates T cell proliferation in vitro |
12/22/2009 | US7635754 Interleukin-9 and interleukin-4 chimeric antagonist muteins and methods of using same |
12/22/2009 | US7635752 Ablated SLAM-Dependent Entry |
12/22/2009 | US7635749 Methods and compositions for prolonging elimination half-times of bioactive compounds |
12/22/2009 | US7635688 Gene expression vectors; intensifier dor sequence determiantion; induce immunology response; viricides |
12/22/2009 | US7635687 Vector system |
12/22/2009 | US7635686 Cancer treatment with a synthetic sequences |
12/22/2009 | US7635681 Cell-permeable peptide inhibitors of the JNK signal transduction pathway |
12/22/2009 | US7635679 A polypeptide variant of the human HMGB1 high affinity binding domain Box-A (HMGB1 Box-A); more favorable pharmacokinetic and pharmacodynamic profiles; diagnose, prevent, or treat pathologies associated with extracellular HMGB1 and associated with RAGE ( receptor for advanced glycation end products ) |
12/22/2009 | US7635677 polypeptides related to a receptor to BAFF (a B-cell activating factor belonging to the Tumor Necrosis Factor family, which is associated with theexpression of B-cells and immunoglobulins); this receptor can be employed in the treatment of cancers, lymphomas, autoimmune diseases related to B-cells |
12/22/2009 | US7635673 Gene expression inhibition via contacting with tyrphostin; liposomes; drug screening |
12/22/2009 | US7635666 Methods for producing members of specific binding pairs |
12/22/2009 | US7635582 Process for the production of triacylglycerols |
12/22/2009 | US7635580 Using transgenic corynebacterium as bioreactor for fermentation of methionine; supplementing/enhancing animal feeds |
12/22/2009 | US7635579 Metabolic engineering of amino acid production |
12/22/2009 | US7635578 Sequencing; solid phase synthesis; primer hybridization |
12/22/2009 | US7635576 CC-chemokine binding tick proteins |
12/22/2009 | US7635569 Generating and identifying polypeptide stability, folding and/or solubility mutants comprising; mutagenizing gene sequences, expressing in host cell, determine protein structure; screening a candidate modulator |
12/22/2009 | US7635567 Method for determination of the responsiveness of an individual to mistletoe lectin |
12/22/2009 | US7635565 Analyzing blood type with identification of patient by genotyping |
12/22/2009 | US7635559 Hybridization, immobilization; genotypes |
12/22/2009 | US7635558 Method for analyzing nucleic acid and use thereof for evaluating the degree of mRNA editing of the serotonin 5-HT2C receptor |
12/22/2009 | US7635557 Using protease digestion as diagnostic tool in detection of viral particles associated with severe acute respiratory syndrome (SARS) |
12/22/2009 | US7635486 Where lipidation thereof is from expression of first nucleic acid sequence and protein portion thereof is from expression of second nucleic acid sequence and first and second sequences do not naturally occur together, such as a lipoprotein where first sequence encodes Borrelia lipoprotein, second, PsaA |
12/22/2009 | US7635483 Enzymatically inactive streptococcal C5a peptidase (SCP) conjugated or linked to one or more peptides; effective in immunizing a susceptible mammal against beta-hemolytic Streptococcus |
12/22/2009 | US7635480 Peptides for preventing, diagnosing and treating animal and/or human leptospirosis |
12/22/2009 | US7635479 comprising fusion protein biodrug as antitumor agent; contains amino acid sequence from prokaryotic organism such as a Listeria species protein, an ActA protein, a Streptolysin protein; immunotherapy |
12/22/2009 | US7635478 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
12/22/2009 | US7635476 Chimpanzee monoclonal antibodies and antigen binding fragments including variable region peptides; bioassay for detection of hepatitis A virus; diagnosis, treatment and prevention of hepatitis; kits |
12/22/2009 | US7635475 Diabody-type bispecific antibody |
12/22/2009 | US7635466 treating human cancers or tumors with biodrug; amino acid sequences; viricides; anticarcinogenic agent |
12/22/2009 | CA2450142C Direct binding assay for identifying inhibitors of hcv polymerase |
12/22/2009 | CA2373330C Profile searching in nucleic acid sequences using the fast fourier transformation |
12/22/2009 | CA2354024C A recombinant vector expressing multiple costimulatory molecules and uses thereof |
12/22/2009 | CA2336541C Modulation of polypeptide display on modified filamentous phage |
12/22/2009 | CA2323607C Immunological methods to modulate myostatin in vertebrate subjects |
12/22/2009 | CA2304929C Stable zymomonas mobilis xylose and arabinose fermenting strains |
12/22/2009 | CA2297158C Methods and compounds for analyzing nucleic acids by mass spectrometry |
12/22/2009 | CA2232542C Novel polypeptides and polynucleotides relating to the .alpha.- and .beta.-subunits of glutamate dehydrogenases and methods of use |
12/22/2009 | CA2231349C Amplifications of chromosomal region 20q13 as a prognostic indicator in breast cancer |
12/22/2009 | CA2216805C Control of pod dehiscence |
12/22/2009 | CA2186144C Luciferases |
12/22/2009 | CA2180309C Coccidiosis poultry vaccine |
12/22/2009 | CA2145761C Nucleic acid ligands and methods for producing the same |
12/22/2009 | CA2104871C Prad1 cyclin (cyclin d1) and its cdna |
12/19/2009 | CA2633246A1 Identification of therapeutic agents for hiv infection |
12/17/2009 | WO2009152529A2 Programming and reprogramming of cells |
12/17/2009 | WO2009152500A2 Methods and compositions for mediating gene silencing |
12/17/2009 | WO2009152480A2 Methods to treat solid tumors |
12/17/2009 | WO2009152387A2 Compositions comprising cmyc sirna and methods of use thereof |
12/17/2009 | WO2009152364A2 Proteins that fluoresce at infrared wavelengths or generates singlet oxygen upon illumination |
12/17/2009 | WO2009152346A2 Compositions comprising phosphoinositide 3-kinase sirna and methods of use thereof |
12/17/2009 | WO2009152336A1 Method of synthesizing polynucleotide variants |
12/17/2009 | WO2009152285A1 Compositions and methods for producing fermentable carbohydrates in plants |
12/17/2009 | WO2009152224A1 Compositions and methods of use of mitogen-activated protein kinase kinase kinase |
12/17/2009 | WO2009152085A1 Novel bmp-12-related proteins and methods of their manufacture |
12/17/2009 | WO2009152023A1 Novel bacillus thuringiensis gene with lepidopteran activity |
12/17/2009 | WO2009151748A1 Novel bacillus thuringiensis gene with lepidopteran activity |
12/17/2009 | WO2009151697A2 Compositions and processes relating to human bocavirus |
12/17/2009 | WO2009151688A2 Direct selection of structurally defined aptamers |
12/17/2009 | WO2009151605A1 Expression vectors |
12/17/2009 | WO2009151600A2 Smad proteins control drosha-mediated mirna maturation |
12/17/2009 | WO2009151591A2 Methods and compositions for generation of bax- and bak-deficient cell lines |
12/17/2009 | WO2009151584A2 Identification of contaminating bacteria in industrial ethanol fermentations |
12/17/2009 | WO2009151546A2 Methods for treating spinal muscular atrophy |
12/17/2009 | WO2009151491A2 In vivo incorporation of an unnatural amino acid comprising a 1,2-aminothiol group |
12/17/2009 | WO2009151313A1 A novel antiviral peptide against avian influenza virus h9n2 |
12/17/2009 | WO2009151207A1 Mesenchymal stem cells which express human hepatic growth factor, manufacturing method thereof, and use thereof as therapeutic agent for liver diseases |
12/17/2009 | WO2009151172A1 Lentiviral vectors comprising ferritin gene and use thereof |
12/17/2009 | WO2009151165A1 Recombinant sars-c o v n s p 12 and the use thereof, and the method for producing it |
12/17/2009 | WO2009151150A1 Method for detecting or quantifying dna |
12/17/2009 | WO2009151149A1 Method for detecting or quantifying dna |
12/17/2009 | WO2009150858A1 Method for production of glycoprotein characterized by its sugar chain structure by utilizing silkworm |
12/17/2009 | WO2009150856A1 Gene that imparts oxygen resistance and application thereof |
12/17/2009 | WO2009150848A1 Method of directing the evolution of an organism |
12/17/2009 | WO2009150839A1 Diagnosis/treatment option for head-and-neck tumor using micro-rna as biomarker |
12/17/2009 | WO2009150835A1 Iqgap3 epitope peptides and vaccines containing the same |
12/17/2009 | WO2009150789A1 Method for testing for the risk of coronary artery spasm |
12/17/2009 | WO2009150550A2 Genetic component of complications in type 2 diabetes |
12/17/2009 | WO2009150477A2 Gene transfer vehicle and use therefor |
12/17/2009 | WO2009150470A2 Suppression of cancers |
12/17/2009 | WO2009150469A2 Suppression of neuroendocrine diseases |
12/17/2009 | WO2009150456A1 Protein expression |
12/17/2009 | WO2009150442A1 Selection method ii |
12/17/2009 | WO2009150441A1 Mitochondrial transformation |
12/17/2009 | WO2009150435A1 Plastid transformation vectors allowing excision of marker genes |
12/17/2009 | WO2009150431A1 Vector |
12/17/2009 | WO2009150430A2 Vaccine |
12/17/2009 | WO2009150426A2 Method |
12/17/2009 | WO2009150275A1 Human anti-dectin-1 antibody, hybridoma producing said antibody and applications thereof |
12/17/2009 | WO2009150222A2 Improved protein expression system |
12/17/2009 | WO2009150215A2 Hybrid proteins comprising membrane receptor and ion channel, and their use as biosensors |
12/17/2009 | WO2009150195A1 Multi-species polynucleotide control sequences |
12/17/2009 | WO2009150170A1 Methods in increasing grain value by improving grain yield and quality |
12/17/2009 | WO2009150156A1 Method for enzymatic synthesis of chemically modified rna |
12/17/2009 | WO2009149956A2 Fusion protein and use thereof |
12/17/2009 | WO2009149921A2 Inhibition of hrp-3 using modified oligonucleotides |
12/17/2009 | WO2009149910A1 Anti-angiogenic compositions and therapeutic applications thereof |
12/17/2009 | WO2009149787A1 Bollworm insect resistance management in transgenic plants |